Autoimmune hepatitis is a chronic immune-mediated disease characterized by a loss of tolerance against liver resident antigens. The genetic background of autoimmune hepatitis is considered to be polygenic. Here we analyzed the genetic association of the tyrosine phosphatase CD45 and autoimmune hepatitis. CD45 plays an important role in normal antigen receptor mediated signaling in T and B cells. A point mutation at nucleotide position 77 of the CD45 gene results in abnormal CD45 splicing. In this study a significantly higher frequency of the 77 C/G genotype was observed in 190 autoimmune hepatitis patients when compared to 210 healthy blood donors. Our data identify CD45 as a gene associated with AIH, and further substantiates the hypothesis that CD45 represents a modifier gene of human autoimmunity.
Autoimmune hepatitis (AIH) is a chronic inflammatory disease of the liver of unknown etiology. 1 It is widely accepted that genetic factors are involved in the pathogenesis of AIH. This is illustrated by a number of genetic associations, which have been studied during the last years, including genes of human leukocyte antigens, 2 cytotoxic T-lymphocyte antigen 3 and the vitamin D receptor. 4, 5 In this study, we investigated an association of mutations of the CD45 molecule with autoimmune hepatitis. CD45 is a transmembrane tyrosine phosphatase with a key role for antigen receptor mediated signaling of T and B cells. 6, 7 Recent studies indicated that CD45 functions as a positive regulator via dephosphorylation of src kinases but can also function as a Janus kinase PTPase that negatively controls cytokine-receptor signaling. 8, 9 CD45 consists of 35 exons located on chromosome 1q31-32. It is expressed as multiple isoforms ranging from 180 to 220 kDa, which are generated as a result of cell type specific alternative splicing of three exons that encode sequences at the amino terminal domain. 10 The high molecular weight isoform contains exon 4 (A), 5 (B) and 6 (C) (CD45RABC), which are absent in the low molecular weight isoform (CD45R0). Peripheral T cells express both isoforms, but naïve T cells switch from high molecular weight to low molecular weight isoforms upon stimulation. 11 The analysis of T cells revealed an aberrantly high expression level of the high molecular weight CD45 isoforms in some individuals. 12 Changes in CD45 expression may alter immune responses in those patients by affecting activation, adhesion and migration of immune cells. 13 This splice variant was found to be associated with a C-G transition at nucleotide position 77 of exon A in the CD45 gene, 14 and subsequently it was shown that an exonic splicing silencer is disrupted by the mutation. 15 Splice variants of CD45 have been implicated in autoimmunity of humans and mice. 13 In the present study we investigated the frequency of the 77C/G mutation in 190 patients with AIH compared to 210 healthy blood donors. Blood samples were collected from patients seen at Hannover Medical School, Germany. All patients were diagnosed according to the revised criteria of the international autoimmune hepatitis group. 1 Patients and controls were Caucasians and were recruited in Northern Germany. The 77C/G variants were detected as previously reported using PCR and MspI digestion analysis. 13 In our analysis we did not detect a single individual among the 400 studied subjects with a homozygous mutation at position 77 of the CD45 gene. The frequency of the heterozygous variant (3/210) was equivalent to the estimated frequency in European controls. In contrast, the frequency of the 77C/G genotype was significantly higher in our AIH group (12/190) (P ¼ 0.015, Odds ratio 4.65 (95% CI 1.29-16.75) using Fisher exact test (Table 1) . AIH patients carrying the 77C/G variant did not differ from wild-type patients in their clinical presentation regarding age of onset, subtype of autoimmune hepatitis, diseases severity, progression to cirrhosis and frequency of additional autoimmune diseases.
Several conclusions can be drawn from our observation. Firstly, individuals with the CD45 splice variant are very rare in a European control population with an estimated allele frequency of 1.02%. 13, 16 This is significant when results from European patients are compared to other ethnic groups, in which allele frequencies have been found to vary between 0% (African population) and 6.7% (population living in the Pamir mountains of Central Asia). 17 Furthermore, the CD45 splice variant is apparently not the main risk factor for autoimmune hepatitis since most patients do not carry this mutation. However, the identification of immunologically relevant genes is not only crucial to elucidate the etiology of autoimmune diseases but also to define the role of a specific mutation or polymorphism for the risk to develop autoimmune diseases. There is increasing evidence that individual genes are not only involved in the development of one particular autoimmune disease, but also contribute to the genetic background associated with various other autoimmune disorders. Our data support the hypothesis that CD45 represents one of these modifier genes of human autoimmunity. Modifier genes of autoimmunity can be divided into various risk groups ranging from ''high-risk'' to ''low-risk'' genes according to their individual contribution to autoimmune disease development. A model gene for a ''high-risk'' gene is AIRE. Homozygous or compound heterozygous mutations of the AIRE gene cause the APECED syndrome. 5 The spectrum of the phenotype is broad and affected patients can suffer from a variety of autoimmune diseases. Recent findings indicate that common mutations in the AIRE gene do not play a major role in sporadic autoimmune diseases such as autoimmune liver diseases, 18 and are therefore a unique feature of APECED. Interestingly, the autoimmune regulator (AIRE) knock-out mice present like human APECED patients with a variable combination of endocrine and non-endocrine autoimmune disease components. 19 Patients and mice with the same mutation can develop different autoimmune diseases indicating that AIRE provides a strong genetic background against which additional factors such as environmental triggers and/or additional genetic factors lead to the initiation of organspecific autoimmunity.
The debate concerning the role of CD45 is still open but several points indicate that it may confer an intermediate risk. Healthy blood donors carrying 77G/ C are very rare in Europe. Interestingly, one study interviewed all controls and recruited only healthy individuals. They found no CD45 variants among 305 individuals, which corroborates the low gene frequency in healthy individuals. 13 In addition, several studies in animal models support the modifier gene hypothesis of CD45. Disproportional expression of certain CD45 splice isoforms on T-cell subsets has been implicated in the pathogenesis of lupus-like autoimmunity in lpr/gld mice, diabetes in non-obese diabetic mice and experimental encephalomyelitis in SJL/J mice. [20] [21] [22] In conclusion, CD45 is a promising candidate gene implicated to modify the individual risk for human autoimmunity. Further studies are needed to elucidate the pathogenic mechanisms by which the different CD45 splice isoforms contribute to the alteration of immune responses in affected individuals. 
